Portage Biotech (PRTG) Competitors $5.96 +0.11 (+1.88%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PRTG vs. ACXP, TXMD, AIM, HCWB, MRNS, PMCB, KZIA, SLGL, AWH, and WENAShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Acurx Pharmaceuticals (ACXP), TherapeuticsMD (TXMD), AIM ImmunoTech (AIM), HCW Biologics (HCWB), Marinus Pharmaceuticals (MRNS), PharmaCyte Biotech (PMCB), Kazia Therapeutics (KZIA), Sol-Gel Technologies (SLGL), Aspira Women's Health (AWH), and ANEW Medical (WENA). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Acurx Pharmaceuticals TherapeuticsMD AIM ImmunoTech HCW Biologics Marinus Pharmaceuticals PharmaCyte Biotech Kazia Therapeutics Sol-Gel Technologies Aspira Women's Health ANEW Medical Acurx Pharmaceuticals (NASDAQ:ACXP) and Portage Biotech (NASDAQ:PRTG) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk. Do insiders and institutionals have more ownership in ACXP or PRTG? 11.5% of Acurx Pharmaceuticals shares are held by institutional investors. Comparatively, 13.4% of Portage Biotech shares are held by institutional investors. 29.6% of Acurx Pharmaceuticals shares are held by company insiders. Comparatively, 42.1% of Portage Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, ACXP or PRTG? Acurx Pharmaceuticals is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcurx PharmaceuticalsN/AN/A-$14.58M-$1.09-0.76Portage BiotechN/AN/A-$75.34M-$41.65-0.14 Do analysts prefer ACXP or PRTG? Acurx Pharmaceuticals currently has a consensus target price of $12.00, indicating a potential upside of 1,354.55%. Given Acurx Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts plainly believe Acurx Pharmaceuticals is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acurx Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Portage Biotech 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, ACXP or PRTG? Acurx Pharmaceuticals has a beta of -1.86, suggesting that its stock price is 286% less volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Does the media refer more to ACXP or PRTG? In the previous week, Portage Biotech had 10 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 10 mentions for Portage Biotech and 0 mentions for Acurx Pharmaceuticals. Portage Biotech's average media sentiment score of 0.15 beat Acurx Pharmaceuticals' score of 0.00 indicating that Portage Biotech is being referred to more favorably in the news media. Company Overall Sentiment Acurx Pharmaceuticals Neutral Portage Biotech Neutral Does the MarketBeat Community prefer ACXP or PRTG? Acurx Pharmaceuticals received 1 more outperform votes than Portage Biotech when rated by MarketBeat users. Likewise, 93.33% of users gave Acurx Pharmaceuticals an outperform vote while only 59.09% of users gave Portage Biotech an outperform vote. CompanyUnderperformOutperformAcurx PharmaceuticalsOutperform Votes1493.33% Underperform Votes16.67%Portage BiotechOutperform Votes1359.09% Underperform Votes940.91% Is ACXP or PRTG more profitable? Portage Biotech's return on equity of -342.34% beat Acurx Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Acurx PharmaceuticalsN/A -392.36% -223.78% Portage Biotech N/A -342.34%-196.47% SummaryPortage Biotech beats Acurx Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.25M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.1410.5990.0517.20Price / SalesN/A196.061,117.09117.04Price / Cash0.3757.1643.1037.85Price / Book1.595.094.784.78Net Income-$75.34M$151.83M$120.31M$225.60M7 Day Performance98.67%-2.14%-1.92%-1.23%1 Month Performance29.00%-4.56%13.65%0.46%1 Year Performance-78.56%8.87%28.34%15.24% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech1.3517 of 5 stars$5.96+1.9%N/A-76.2%$6.25MN/A-0.146Gap DownACXPAcurx Pharmaceuticals1.3843 of 5 stars$0.83-2.9%$12.00+1,345.8%-77.0%$14.02MN/A-0.783Gap UpTXMDTherapeuticsMD0.4365 of 5 stars$1.20-1.9%N/A-53.8%$13.80M$1.30M0.00420Analyst ForecastGap UpAIMAIM ImmunoTech2.3673 of 5 stars$0.22-1.4%$2.75+1,173.1%-60.4%$13.78M$190,000.00-0.4720HCWBHCW Biologics0.406 of 5 stars$0.36+0.6%N/A-60.4%$13.58M$3.50M-0.3640Gap DownMRNSMarinus Pharmaceuticals4.3176 of 5 stars$0.24-7.0%$4.79+1,857.3%-97.6%$13.49M$31.47M-0.10110Analyst ForecastNews CoveragePMCBPharmaCyte Biotech0.4217 of 5 stars$1.70-1.2%N/A-24.8%$13.05MN/A2.612Earnings ReportKZIAKazia Therapeutics1.7318 of 5 stars$3.91+10.1%$20.00+411.5%-21.6%$13.02M$2.31M0.0012Gap UpSLGLSol-Gel Technologies2.4245 of 5 stars$0.46-4.1%$5.00+987.0%-66.5%$12.82M$1.55M-1.3650AWHAspira Women's Health1.218 of 5 stars$0.76+1.9%$4.40+475.9%-69.7%$12.74M$9.15M-0.62110Analyst ForecastWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap Up Related Companies and Tools Related Companies Acurx Pharmaceuticals Alternatives TherapeuticsMD Alternatives AIM ImmunoTech Alternatives HCW Biologics Alternatives Marinus Pharmaceuticals Alternatives PharmaCyte Biotech Alternatives Kazia Therapeutics Alternatives Sol-Gel Technologies Alternatives Aspira Women's Health Alternatives ANEW Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts